KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 70 filers reported holding KALA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $156,000 | -22.0% | 24,378 | +0.7% | 0.00% | -100.0% |
| Q1 2019 | $200,000 | +69.5% | 24,218 | 0.0% | 0.00% | – |
| Q4 2018 | $118,000 | -34.1% | 24,218 | +33.6% | 0.00% | – |
| Q3 2018 | $179,000 | -29.2% | 18,130 | -1.5% | 0.00% | -100.0% |
| Q2 2018 | $253,000 | -13.1% | 18,410 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $291,000 | -16.9% | 18,410 | -2.7% | 0.00% | 0.0% |
| Q4 2017 | $350,000 | -17.6% | 18,928 | +1.8% | 0.00% | 0.0% |
| Q3 2017 | $425,000 | – | 18,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |